Presentation, complications, and treatment outcome of brucellosis in Turkish children

Gonul Tanir1, Sehra B Tufekci, Nilden Tuygun

  • 1Department of Pediatrics, Dr Sami Ulus Children's Health and Diseases Training and Research Center, Ankara, Turkey. gonultanir58@yahoo.com

Insights

Childhood brucellosis in Turkey is often caused by unpasteurized milk. Effective treatments with co-trimoxazole or doxycycline plus rifampicin lead to rapid improvement and low relapse rates.

Area of Science:

  • Infectious Diseases
  • Pediatrics
  • Public Health

Background:

  • Brucellosis is a significant public health concern in Turkey, with children comprising 20-25% of cases.
  • Endemic Brucella melitensis areas necessitate focused research on pediatric brucellosis.

Purpose of the Study:

  • To retrospectively evaluate clinical characteristics and treatment outcomes of childhood brucellosis in Turkey.
  • To identify common transmission routes, clinical presentations, and complications in pediatric brucellosis patients.

Main Methods:

  • Retrospective analysis of hospital records for 90 children diagnosed with brucellosis between 1997 and 2006.
  • Evaluation of patient demographics, transmission sources, clinical findings, diagnostic tests, treatment regimens, and outcomes.

Main Results:

  • The majority of pediatric brucellosis cases (70%) were male, with a mean age of 9.02 years.
  • Consumption of unpasteurized milk/dairy products was the primary transmission route (71.1%).
  • Joint involvement (arthralgia, arthritis) was common, with rapid response to treatment; however, complications like neurobrucellosis occurred in some patients.

Conclusions:

  • Combined antibiotic therapy (co-trimoxazole or doxycycline with rifampicin) is effective for childhood brucellosis, achieving low relapse rates.
  • Triple-drug regimens successfully treated complications and relapses, with minimal long-term sequelae.
Abstract